BARDA

BARDA

Biodefense Headlines – 28 February 2025

News Scan February 28, 2025

This week’s topics include the retreat of U.S. support for global and domestic health security, outbreak of deadly unknown disease in the Democratic Republic of Congo, the ongoing Ebola outbreak…

Notable Biodefense Contracts: $89M to Basilea Pharmaceutica

Biodefense News Headlines of the Week – June 16, 2013

FDA Lifts Clinical Hold On PharmAthene’s Anthrax Vaccine Program

Notable Contracts: Cempra Biodefense Antibiotic for Children

BARDA Partners with GSK for Hospital and Biothreat Antibacterials

BARDA Seeks Vaccine Ancillary Materials for Pandemic Preparedness

Novavax Initiates Animal Testing of H7N9 VLP Vaccine

GAO Says 60 Percent of CBRN National Stockpile Approved for Children

CBRN Diagnostics Broad Agency Announcement

BARDA Public Health and Medical Consequence Modeling Network

HHS Awards Contract to Create Test to Identify Resistant Influenza Viruses

Glaxo Teams with Texas A&M for Influenza Manufacturing Center of Excellence

Government Building ‘Fill and Finish’ Network for Pandemic Influenza Vaccines

FDA Approves First Antitoxin to Neutralize All 7 Botulism Serotypes

CBRN Medical Countermeasures Clinical Studies Network

Obama Signs Pandemics and All-Hazards Preparedness Act of 2013

SIGA Begins Smallpox Drug Shipments to National Stockpile

FDA Approves Raxibacumab to Treat Inhalational Anthrax

Emergent BioSolutions Secures Rights to Pandemic Influenza Vaccine Candidate

Novartis Receives FDA Approval for First Cell-Culture Influenza Vaccine

Biodefense Headlines – 28 February 2025